The effect of β-carotene on the mortality of male smokers is modified by smoking and by vitamins C and E: evidence against a uniform effect of nutrient

Harri Hemilä, Harri Hemilä

Abstract

A previous analysis of the Alpha-Tocopherol Beta-Carotene (ATBC) Study on male smokers found that β-carotene supplementation increased the risk of pneumonia 4-fold in those who started smoking at the age of ≥21 years and smoked ≥21 cigarettes/d (a subgroup of 7 % of the study population). The present study hypothesised that β-carotene increases mortality in the same subgroup. The ATBC Study (1985-1993) recruited 29 133 Finnish male smokers (≥5 cigarettes/d) aged 50-69 years. Cox regression models were constructed to estimate the effect of β-carotene supplementation in subgroups. β-Carotene increased mortality (risk ratio 1·56; 95 % CI 1·06, 2·3) in those who started to smoke at ≥21 years and smoked ≥21 cigarettes/d. Within this subgroup, there was strong evidence of further heterogeneity. The effect of β-carotene supplementation was further modified by dietary vitamin C intake, fruit and vegetable intake (P = 0·0004), and by vitamin E supplementation (P = 0·011). Thus, harm from β-carotene was not uniform within the study population. Interactions between β-carotene and vitamins C and E were seen only within a subgroup of 7 % of the ATBC participants, and therefore should not be extrapolated to the general population. Heterogeneity of the β-carotene effect on mortality challenges the validity of previous meta-analyses that have pooled many diverse antioxidants for one single estimate of effect using the assumption that a single estimate equally applies to all antioxidants and all people. Trial registration: ClinicalTrials.gov NCT00342992.

Keywords: AT, all rac-α-tocopheryl acetate; ATBC, Alpha-Tocopherol Beta-Carotene; Antioxidants; BC, β-carotene; Cohort studies; Dietary supplements; Effect modifiers; Oxidative stress; Population characteristics; RR, risk ratio; Randomised controlled trials.

© The Author(s) 2020.

Figures

Fig. 1.
Fig. 1.
Mortality by β-carotene (BC) supplementation: participants who initiated smoking at ≥21 years and smoked ≥21 cigarettes/d (Alpha-Tocopherol Beta-Carotene Study 1985–1993). The Kaplan–Meier survival curves for the BC and placebo arms are shown. Each step indicates one death. (a) Mortality after randomisation. For the difference between the two curves, P = 0·024. (b) Mortality by follow-up age.
Fig. 2.
Fig. 2.
Effect of vitamin C intake, and fruit and vegetable intake on the mortality caused by β-carotene (BC) supplementation: participants who initiated smoking at ≥21 years and smoked ≥21 cigarettes/d in male smokers (Alpha-Tocopherol Beta-Carotene Study 1985–1993). ○, Deaths in the placebo arm; ●, deaths in the BC arm. Assuming that BC had no effect on mortality, we would expect a similar distribution of deaths in the placebo and BC arms. The cut-off limits used in the statistical analysis are shown: 90 mg/d vitamin C and 275 g/d fruit and vegetables. The subgroup labels A, B and C are as used in Table 3.
Fig. 3.
Fig. 3.
Mortality caused by β-carotene (BC) supplementation in subgroups A to C of Fig. 2 in male smokers (Alpha-Tocopherol Beta-Carotene Study 1985–1993). The Kaplan–Meier survival curves are shown for the BC and placebo arms. Each step indicates one death. (a) Subgroup A: vitamin C P = 0·004. (b) Subgroup B: vitamin C ≥90 mg/d and fruit and vegetables <275 g/d, P = 0·049. (c) Subgroup C: vitamin C ≥90 mg/d and fruit and vegetable intake ≥275 g/d, P = 0·004.
Fig. 4.
Fig. 4.
Meta-analysis to examine heterogeneity in the effects of β-carotene (BC) on mortality within the Alpha-Tocopherol Beta-Carotene Study. This meta-analysis is restricted to the 14 564 no-vitamin E participants. Subgroups A, B and C are described in Fig. 2 and Table 3. The participants who smoked between 5 and 19 cigarettes (Cig)/d (median 12/d), are separated into their own subgroup. ‘The rest’ means all the remaining participants. The percentage after the study label indicates the proportion of all participants in the particular subgroup. The horizontal lines indicate the 95 % CI for the BC effect and the squares in the middle of the horizontal lines indicate the point estimates of the effect in the particular subgroup. The diamond shape indicates the pooled effect and its 95 % confidence interval. RR, risk ratio.

References

    1. Bjelakovic G, Nikolova D, Gluud LL, et al. (2007) Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis. JAMA 297, 842–857.
    1. Burton GW & Ingold KU (1984) β-Carotene: an unusual type of lipid antioxidant. Science 224, 569–573.
    1. Pryor WA, Stahl W & Rock CL (2000) β Carotene: from biochemistry to clinical trials. Nutr Rev 58, 39–53.
    1. Halliwell B & Gutteridge JMC (2007) Free Radicals in Biology and Medicine, 4th ed., pp. 160–179. Oxford: Oxford University Press.
    1. Institute of Medicine (2000) Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids. Washington, DC: National Academies Press.
    1. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330, 1029–1035.
    1. Anonymous (1994) The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol 4, 1–10.
    1. Albanes D, Heinonen OP, Taylor PR, et al. (1996) α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: effects of base-line characteristics and study compliance. J Natl Cancer Inst 88, 1560–1570.
    1. Hemilä H, Virtamo J, Albanes D, et al. (2006) The effect of vitamin E on common cold incidence is modified by age, smoking and residential neighborhood. J Am Coll Nutr 25, 332–339.
    1. Hemilä H, Virtamo J, Albanes D, et al. (2004) Vitamin E and β-carotene supplementation and hospital-treated pneumonia incidence in male smokers. Chest 125, 557–565.
    1. Hemilä H & Kaprio J (2011) Subgroup analysis of large trials can guide further research: a case study of vitamin E and pneumonia. Clin Epidemiol 3, 51–59.
    1. Hemilä H (2016) Vitamin E and the risk of pneumonia: using the I2-statistic to quantify heterogeneity within a controlled trial. Br J Nutr 116, 1530–1536.
    1. Hemilä H (2016) Vitamin E administration may decrease the incidence of pneumonia in elderly males. Clin Interv Aging 11, 1379–1385.
    1. Hemilä H & Kaprio J (2008) Vitamin E supplementation may transiently increase tuberculosis risk in males who smoke heavily and have high dietary vitamin C intake [discussion in (2009) 101, 145–147]. Br J Nutr 100, 896–902.
    1. Hemilä H & Kaprio J (2009) Modification of the effect of vitamin E supplementation on the mortality of male smokers by age and dietary vitamin C. Am J Epidemiol 169, 946–953.
    1. Hemilä H & Kaprio J (2011) Vitamin E may affect the life expectancy of men, depending on dietary vitamin C intake and smoking. Age Ageing 40, 215–220.
    1. Hemilä H (2009) Vitamin E is likely to affect mortality even at low doses. Clin Trials 6, 392–393.
    1. Hemilä H (1997) Vitamin C intake and susceptibility to the common cold [discussion in (1997) 78, 859–866]. Br J Nutr 77, 59–72.
    1. Hemilä H & Chalker E (2013) Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev, issue 1, CD000980.
    1. Hemilä H (1996) Vitamin C and common cold incidence: a review of studies with subjects under heavy physical stress. Int J Sports Med 17, 379–383.
    1. Hemilä H & Suonsyrjä T (2017) Vitamin C for preventing atrial fibrillation in high risk patients: a systematic review and meta-analysis. BMC Cardiovasc Disord 17, 49.
    1. Hemilä H (2010) The effect of β-carotene on common cold incidence is modified by age and smoking: evidence against a uniform effect in a nutrient–disease relationship. Nutr Diet Suppl 2, 117–124.
    1. Hemilä H (2018) Effect of β-carotene supplementation on the risk of pneumonia is heterogeneous in males: effect modification by cigarette smoking. J Nutr Sci Vitaminol (Tokyo) 64, 374–378.
    1. Albanes D, Virtamo J, Taylor PR, et al. (1997) Effects of supplemental β-carotene, cigarette smoking, and alcohol consumption on serum carotenoids in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Clin Nutr 66, 366–372.
    1. Pietinen P, Hartman AM, Haapa E, et al. (1988) Reproducibility and validity of dietary assessment instruments. I. A self-administered food use questionnaire with a portion size picture booklet. Am J Epidemiol 128, 655–666.
    1. Ovaskainen ML, Valsta M & Lauronen J (1996) The compilation of food analysis values as a database for dietary studies: the Finnish experience. Food Chem 57, 133–136.
    1. Hemilä H, Virtamo J, Albanes D, et al. (2003) Physical activity and the common cold in men administered vitamin E and β-carotene. Med Sci Sports Exerc 35, 1815–1820.
    1. R Core Team (2019) R project for statistical computing. (accessed November 2019).
    1. Higgins JPT, Thompson SG, Deeks JJ, et al. (2003) Measuring inconsistency in meta-analysis. Br Med J 327, 557–560.
    1. Hemilä H, Kaprio J, Pietinen P, et al. (1999) Vitamin C and other compounds in vitamin C rich food in relation to risk of tuberculosis in male smokers. Am J Epidemiol 150, 632–641.
    1. Peto R, Doll R, Buckley JD, et al. (1981) Can dietary β-carotene materially reduce human cancer rates? Nature 290, 201–208.
    1. Virtamo J, Pietinen P, Huttunen JK, et al. (2003) Incidence of cancer and mortality following α-tocopherol and β-carotene supplementation: a postintervention follow-up. JAMA 290, 476–485.
    1. Omenn GS, Goodman GE, Thornquist MD, et al. (1996) Effects of a combination of β carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334, 1150–1155.
    1. Omenn GS, Goodman GE, Thornquist MD, et al. (1996) Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst 88, 1550–1559.
    1. Goodman GE, Thornquist MD, Balmes J, et al. (2004) The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping β-carotene and retinol supplements. J Natl Cancer Inst 96, 1743–1750.
    1. Hennekens CH, Buring JE, Manson JE, et al. (1996) Lack of effect of long-term supplementation with β carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334, 1145–1149.
    1. Cook NR, Le IM, Manson JE, et al. (2000) Effects of β-carotene supplementation on cancer incidence by baseline characteristics in the Physicians Health Study (United States). Cancer Causes Control 11, 617–626.
    1. Greenberg ER & Sporn MB (1996) Antioxidant vitamins, cancer, and cardiovascular disease. N Engl J Med 334, 1189–1190.
    1. Mayne ST, Handelman GJ & Beecher G (1996) β-Carotene and lung cancer promotion in heavy smokers: a plausible relationship? J Natl Cancer Inst 88, 1513–1515.
    1. Crabtree DV & Adler AJ (1997) Is β-carotene an antioxidant? Med Hypotheses 48, 183–187.
    1. Omenn GS (1998) Chemoprevention of lung cancer: the rise and demise of β-carotene. Annu Rev Public Health 19, 73–99.
    1. Albanes D (1999) β-Carotene and lung cancer: a case study. Am J Clin Nutr 69, 1345S–1350S.
    1. Cooper DA, Eldridge AL & Peters JC (1999) Dietary carotenoids and lung cancer: a review of recent research. Nutr Rev 57, 133–145.
    1. Solomons NW (1999) Giving a bad name to a perfectly good nutrient. Nutr Rev 57, 327–328.
    1. Marshall JR (1999) β-Carotene: a miss for epidemiology. J Natl Cancer Inst 91, 2068–2069.
    1. Greenwald P (2003) β-Carotene and lung cancer: a lesson for future chemoprevention investigations? J Natl Cancer Inst 95, E1.
    1. Lowe GM, Vlismas K & Young AJ (2003) Carotenoids as prooxidants? Mol Aspects Med 24, 363–369.
    1. Omenn GS (2004) Human lung cancer chemoprevention strategies. Chest 125, 123S–127S.
    1. Duffield-Lillico AJ & Begg CB (2004) Reflections on the landmark studies of β-carotene supplementation. J Natl Cancer Inst 96, 1729–1731.
    1. Hercberg S (2005) The history of β-carotene and cancers: from observational to intervention studies: what lessons can be drawn for future research on polyphenols? Am J Clin Nutr 81, 218S–222S.
    1. Omenn GS (2007) Chemoprevention of lung cancers: lessons from CARET, the Beta-Carotene and Retinol Efficacy Trial, and prospects for the future. Eur J Cancer Prev 16, 184–191.
    1. Shete V & Quadro L (2013) Mammalian metabolism of β-carotene: gaps in knowledge. Nutrients 5, 4849–4868.
    1. Moran NE, Mohn ES, Hason N, et al. (2018) Intrinsic and extrinsic factors impacting absorption, metabolism, and health effects of dietary carotenoids. Adv Nutr 9, 465–492.
    1. Alberg AJ (2002) The influence of cigarette smoking on circulating concentrations of antioxidant micronutrients. Toxicology 180, 121–137.
    1. Dietrich M, Block G, Norkus EP, et al. (2003) Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase γ-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr 77, 160–166.
    1. Gabriel HE, Liu Z, Crott JW, et al. (2006) A comparison of carotenoids, retinoids, and tocopherols in the serum and buccal mucosa of chronic cigarette smokers versus nonsmokers. Cancer Epidemiol Biomarkers Prev 15, 993–999.
    1. Sugiura M, Nakamura M, Ogawa K, et al. (2009) Synergistic interaction of cigarette smoking and alcohol drinking with serum carotenoid concentrations: findings from a middle-aged Japanese population. Br J Nutr 102, 1211–1219.
    1. Widome R, Jacobs DR, Hozawa A, et al. (2010) Passive smoke exposure and circulating carotenoids in the CARDIA study. Ann Nutr Metab 56, 113–118.
    1. Brown AJ (1996) Acute effects of smoking cessation on antioxidant status. J Nutr Biochem 7, 29–39.
    1. Handelman GJ, van Kuijk FJ, Chatterjee A, et al. (1991) Characterization of products formed during the autoxidation of β-carotene. Free Radic Biol Med 10, 427–437.
    1. Kennedy TA & Liebler DC (1991) Peroxyl radical oxidation of β-carotene: formation of β-carotene epoxides. Chem Res Toxicol 4, 290–295.
    1. Kennedy TA & Liebler DC (1992) Peroxyl radical scavenging by β-carotene in lipid bilayers: effect of oxygen partial pressure. J Biol Chem 267, 4658–4663.
    1. Mordi RC, Walton JC, Burton GW, et al. (1993) Oxidative degradation of β-carotene and β-apo-8′-carotenal. Tetrahedron 49, 911–928.
    1. Handelman GJ, Packer L & Cross CE (1996) Destruction of tocopherols, carotenoids, and retinol in human plasma by cigarette smoke. Am J Clin Nutr 63, 559–565.
    1. Liebler DC & McClure TD (1996) Antioxidant reactions of β-carotene: identification of carotenoid-radical adducts. Chem Res Toxicol 9, 8–11.
    1. Baker DL, Krol ES, Jacobsen N, et al. (1999) Reactions of β-carotene with cigarette smoke oxidants: identification of carotenoid oxidation products and evaluation of the prooxidant/antioxidant effect. Chem Res Toxicol 12, 535–543.
    1. Arora A, Willhite CA & Liebler DC (2001) Interactions of β-carotene and cigarette smoke in human bronchial epithelial cells. Carcinogenesis 22, 1173–1178.
    1. Rahman A, Bokhari SS & Waqar MA (2001) β-Carotene degradation by cigarette smoke in hexane solution in vitro. Nutr Res 21, 821–829.
    1. Hurst JS, Contreras JE, Siems WG, et al. (2004) Oxidation of carotenoids by heat and tobacco smoke. Biofactors 20, 23–35.
    1. Hemilä H & Wikström M (1985) Retinoids activate superoxide production by polymorphonuclear leucocytes. Scand J Immunol 21, 227–234.
    1. Gradelet S, Leclerc J, Siess MH, et al. (1996) β-Apo-8'-carotenal, but not β-carotene, is a strong inducer of liver cytochromes P4501A1 and 1A2 in rat. Xenobiotica 26, 909–919.
    1. Paolini M, Cantelli-Forti G, Perocco P, et al. (1999) Co-carcinogenic effect of β-carotene. Nature 398, 760–761.
    1. Salgo MG, Cueto R, Winston GW, et al. (1999) β-Carotene and its oxidation products have different effects on microsome mediated binding of benzo[a]pyrene to DNA. Free Radic Biol Med 26, 162–173.
    1. Wang XD, Liu C, Bronson RT, et al. (1999) Retinoid signaling and activator protein-1 expression in ferrets given β-carotene supplements and exposed to tobacco smoke. J Natl Cancer Inst 91, 60–66.
    1. Wang XD & Russell RM (1999) Procarcinogenic and anticarcinogenic effects of β-carotene. Nutr Rev 57, 263–272.
    1. Siems WG, Sommerburg O, Hurst JS, et al. (2000) Carotenoid oxidative degradation products inhibit Na-K-ATPase. Free Radic Res 33, 427–435.
    1. Paolini M, Antelli A, Pozzetti L, et al. (2001) Induction of cytochrome P450 enzymes and over-generation of oxygen radicals in β-carotene supplemented rats. Carcinogenesis 22, 1483–1495.
    1. Siems W, Sommerburg O, Schild L, et al. (2002) β-Carotene cleavage products induce oxidative stress in vitro by impairing mitochondrial respiration. FASEB J 16, 1289–1291.
    1. Liu C, Russell RM & Wang XD (2003) Exposing ferrets to cigarette smoke and a pharmacological dose of β-carotene supplementation enhance in vitro retinoic acid catabolism in lungs via induction of cytochrome P450 enzymes. J Nutr 133, 173–179.
    1. Siems W, Capuozzo E, Crifo C, et al. (2003) Carotenoid cleavage products modify respiratory burst and induce apoptosis of human neutrophils. Biochim Biophys Acta 1639, 27–33.
    1. Sommerburg O, Langhans CD, Arnhold J, et al. (2003) β-Carotene cleavage products after oxidation mediated by hypochlorous acid – a model for neutrophil-derived degradation. Free Radic Biol Med 35, 1480–1490.
    1. Palozza P, Serini S, Di Nicuolo F, et al. (2004) β-Carotene exacerbates DNA oxidative damage and modifies p53-related pathways of cell proliferation and apoptosis in cultured cells exposed to tobacco smoke condensate. Carcinogenesis 25, 1315–1325.
    1. Russell RM (2004) The enigma of β-carotene in carcinogenesis: what can be learned from animal studies. J Nutr 134, 262S–268S.
    1. Hurst JS, Saini MK, Jin GF, et al. (2005) Toxicity of oxidized β-carotene to cultured human cells. Exp Eye Res 81, 239–243.
    1. Salerno C, Crifo C, Capuozzo E, et al. (2005) Effect of carotenoid oxidation products on neutrophil viability and function. Biofactors 24, 185–192.
    1. Siems W, Wiswedel I, Salerno C, et al. (2005) β-Carotene breakdown products may impair mitochondrial functions – potential side effects of high-dose β-carotene supplementation. J Nutr Biochem 16, 385–197.
    1. Alija A.J, Bresgen N, Sommerburg O, et al. (2006) β-Carotene breakdown products enhance genotoxic effects of oxidative stress in primary rat hepatocytes. Carcinogenesis 27, 1128–1133.
    1. Palozza P, Serini S, Trombino S, et al. (2006) Dual role of β-carotene in combination with cigarette smoke aqueous extract on the formation of mutagenic lipid peroxidation products in lung membranes: dependence on pO2. Carcinogenesis 27, 2383–2391.
    1. Palozza P, Serini S, Currò D, et al. (2006) β-Carotene and cigarette smoke condensate regulate heme oxygenase-1 and its repressor factor Bach1: relationship with cell growth. Antioxid Redox Signal 8, 1069–1080.
    1. van Helden YG, Keijer J, Knaapen AM, et al. (2009) β-Carotene metabolites enhance inflammation-induced oxidative DNA damage in lung epithelial cells. Free Radic Biol Med 46, 299–304.
    1. van Helden YG, Keijer J, Heil SG, et al. (2009) β-Carotene affects oxidative stress-related DNA damage in lung epithelial cells and in ferret lung. Carcinogenesis 30, 2070–2076.
    1. Alija AJ, Bresgen N, Bojaxhi E, et al. (2010) Cytotoxicity of β-carotene cleavage products and its prevention by antioxidants. Acta Biochim Pol 57, 217–221.
    1. Kalariya NM, Ramana KV, Srivastava SK, et al. (2011) Post-translational protein modification by carotenoid cleavage products. Biofactors 37, 104–116.
    1. Eroglu A, Hruszkewycz DP, dela Sena C, et al. (2012) Naturally-occurring eccentric cleavage products of provitamin A carotene β-carotene function as antagonists of retinoic acid receptors. J Biol Chem 287, 15886–15895.
    1. Harrison EH, dela Sena C, Eroglu A, et al. (2012) The formation, occurrence and function of β-apocarotenoids: β-carotene metabolites that may modulate nuclear receptor signaling. Am J Clin Nutr 96, 1189–1192.
    1. Eroglu A & Harrison EH (2013) Carotenoid metabolism in mammals, including man: formation, occurrence, and function of apocarotenoids. J Lipid Res 54, 1719–1730.
    1. Stutz H, Bresgen N & Eckl PM (2015) Analytical tools for the analysis of β-carotene and its degradation products. Free Radic Res 49, 650–680.
    1. Haider C, Ferk F, Bojaxhi E, et al. (2017) Effects of β-carotene and its cleavage products in primary pneumocyte type II cells. Antioxidants (Basel) 6, 37.
    1. Su D, Wang X, Campbell MR, et al. (2016) Distinct epigenetic effects of tobacco smoking in whole blood and among leukocyte subtypes. PLOS ONE 11, e0166486.
    1. de Vries M, van der Plaat DA, Nedeljkovic I, et al. (2018) From blood to lung tissue: effect of cigarette smoke on DNA methylation and lung function. Respir Res 19, 212.
    1. Gold DR, Wang XB, Wypij D, et al. (1996) Effects of cigarette smoking on lung function in adolescent boys and girls. N Engl J Med 335, 931–937.
    1. Apostol GG, Jacobs DR, Tsai AW, et al. (2002) Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study. Am J Respir Crit Care Med 166, 166–172.
    1. Patel BD, Luben RN, Welch AA, et al. (2004) Childhood smoking is an independent risk factor for obstructive airways disease in women. Thorax 59, 682–686.
    1. Jialal I & Grundy SM (1991) Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest 87, 597–601.
    1. Packer L (1993) Antioxidant action of carotenoids in vitro and in vivo and protection against oxidation of human low-density lipoproteins. Ann N Y Acad Sci 691, 48–60.
    1. Böhm F, Edge R, Land EJ, et al. (1997) Carotenoids enhance vitamin E antioxidant efficiency. J Am Chem Soc 119, 621–622.
    1. Burke M, Edge R, Land EJ, et al. (2001) Characterisation of carotenoid radical cations in liposomal environments: interaction with vitamin C. J Photochem Photobiol B 60, 1–6.
    1. Yeum KJ, Beretta G, Krinsky NI, et al. (2009) Synergistic interactions of antioxidant nutrients in a biological model system. Nutrition 25, 839–846.
    1. Liu C, Russell RM & Wang XD (2004) α-Tocopherol and ascorbic acid decrease the production of β-apo-carotenals and increase the formation of retinoids from β-carotene in the lung tissues of cigarette smoke-exposed ferrets in vitro. J Nutr 134, 426–430.
    1. van den Berg H (1999) Carotenoid interactions. Nutr Rev 57, 1–10.
    1. Palozza P & Krinsky NI (1992) β-Carotene and α-tocopherol are synergistic antioxidants. Arch Biochem Biophys 297, 184–187.
    1. Liebler DC, Stratton SP & Kaysen KL (1997) Antioxidant actions of β-carotene in liposomal and microsomal membranes: role of carotenoid-membrane incorporation and α-tocopherol. Arch Biochem Biophys 338, 244–250.
    1. Perocco P, Mazzullo M, Broccoli M, et al. (2000) Inhibitory activity of vitamin E and α-naphthoflavone on β-carotene-enhanced transformation of BALB/c 3T3 cells by benzo(a)pyrene and cigarette-smoke condensate. Mutat Res 465, 151–158.
    1. Yeum KJ, dos Anjos Ferreira AL, Smith D, et al. (2000) The effect of α-tocopherol on the oxidative cleavage of β-carotene. Free Radic Biol Med 29, 105–114.
    1. Hemilä H & Kaprio J (2008) Vitamin E supplementation and pneumonia risk in males who initiated smoking at an early age: effect modification by body weight and dietary vitamin C. Nutr J 7, 33.
    1. Leo MA & Lieber CS (1999) Alcohol, vitamin A, and β-carotene: adverse interactions, including hepatotoxicity and carcinogenicity. Am J Clin Nutr 69, 1071–1085.
    1. Hemilä H (2007) Antioxidant supplements and mortality. JAMA 298, 401.
    1. Heyland DK, Dhaliwal R, Suchner U, et al. (2005) Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 31, 327–337.
    1. Bardia A, Tleyjeh IM, Cerhan JR, et al. (2008) Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin Proc 83, 23–34.
    1. Manzanares W, Dhaliwal R, Jiang X, et al. (2012) Antioxidant micronutrients in the critically ill: a systematic review and meta-analysis. Crit Care 16, R66.
    1. Myung SK, Ju W, Cho B, et al. (2013) Efficacy of vitamin and antioxidant supplements in prevention of cardiovascular disease: systematic review and meta-analysis of randomised controlled trials. Br Med J 346, f10.
    1. Ye Y, Li J & Yuan Z (2013) Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-analysis of randomized controlled trials. PLOS ONE 8, e56803.
    1. Langlois PL, Manzanares W, Adhikari NKJ, et al. (2019) Vitamin C administration to the critically ill: a systematic review and meta-analysis. JPEN J Parenter Enteral Nutr 43, 335–346.
    1. Putzu A, Daems AM, Lopez-Delgado JC, et al. (2019) The effect of vitamin C on clinical outcome in critically ill patients: a systematic review with meta-analysis of randomized controlled trials. Crit Care Med 47, 774–783.
    1. Ashor AW, Lara J, Mathers JC, et al. (2012) Effect of vitamin C on endothelial function in health and disease: a systematic review and meta-analysis of randomised controlled trials. Atherosclerosis 235, 9–20.
    1. Juraschek SP, Guallar E, Appel LJ, et al. (2012) Effects of vitamin C supplementation on blood pressure: a meta-analysis of randomized controlled trials. Am J Clin Nutr 95, 1079–1088.
    1. Hemilä H (2014) The effect of vitamin C on bronchoconstriction and respiratory symptoms caused by exercise: a review and statistical analysis. Allergy Asthma Clin Immunol 10, 58.
    1. Pauling L (1971) The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad Sci U S A 68, 2678–2681.
    1. Hemilä H (1996) Vitamin C supplementation and common cold symptoms: problems with inaccurate reviews. Nutrition 12, 804–809.
    1. Hemilä H (2017) Vitamin C and infections. Nutrients 9, 339.
    1. Chen S, Roffey DM, Dion CA, et al. (2016) Effect of perioperative vitamin C supplementation on postoperative pain and the incidence of chronic regional pain syndrome: a systematic review and meta-analysis. Clin J Pain 32, 179–185.
    1. Hemilä H & Chalker E (2019) Vitamin C can shorten the length of stay in the ICU: a meta-analysis. Nutrients 11, 708.
    1. Cohen PA (2014) Hazards of hindsight: monitoring the safety of nutritional supplements. N Engl J Med 370, 1277–1280.
    1. Ribeiro BD, Barreto DW & Coelho MAZ (2011) Technological aspects of β-carotene production. Food Bioproc Tech 4, 693–701.
    1. BCC Research (2018) The Global Market for Carotenoids. (accessed November 2019).

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner